CCDC170
Coiled-coil domain-containing protein 170
Also known as: bA282P11.1, C6orf97, CC170_HUMAN, FLJ23305
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYT3
- Gene
- CCDC170
- Ensembl
- ENSG00000120262
- Chromosome
- 6
- Canonical length
- 715 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Cell Junctions
OverviewNCBI Gene
The function of this gene and its encoded protein is not known. Several genome-wide association studies have implicated the region around this gene to be involved in breast cancer and bone mineral density, but no link to this specific gene has been found. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
715 residues, UniProt reviewed canonical sequence.
>Q8IYT3|CCDC170
1 MSLDCTSHIA LGAASPAPEE TYDHLSEVPV TREQLNHYRN VAQNARSELA ATLVKFECAQ
61 SELQDLRSKM LSKEVSCQEL KAEMESYKEN NARKSSLLTS LRDRVQELEE ESAALSTSKI
121 RTEITAHAAI KENQELKKKV VELNEKLQKC SKENEENKKQ VSKNCRKHEE FLTQLRDCLD
181 PDERNDKASD EDLILKLRDL RKENEFVKGQ IVILEETINV HEMEAKASRE TIMRLASEVN
241 REQKKAASCT EEKEKLNQDL LSAVEAKEAL EREVKIFQER LLAGQQVWDA SKQEVSLLKK
301 SSSELEKSLK ASQDAVTTSQ SQYFSFREKI AALLRGRLSM TGSTEDTILE KIREMDSREE
361 SRDRMVSQLE AQISELVEQL GKESGFHQKA LQRAQKAENM LETLQGQLTH LEAELVSGGV
421 LRDNLNFEKQ KYLKFLDQLS QKMKLDQMAA ELGFDMRLDV VLARTEQLVR LESNAVIENK
481 TIAHNLQRKL KTQKERLESK ELHMSLLRQK IAQLEEEKQA RTALVVERDN AHLTIRNLQK
541 KVERLQKELN TCRDLHTELK AKLADTNELK IKTLEQTKAI EDLNKSRDQL EKMKEKAEKK
601 LMSVKSELDT TEHEAKENKE RARNMIEVVT SEMKTLKKSL EEAEKREKQL ADFREVVSQM
661 LGLNVTSLAL PDYEIIKCLE RLVHSHQHHF VTCACLKDVT TGQERHPQGH LQLLHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCDC170 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 31 nTPM
- choroid plexus: 11 nTPM
- ovary: 6.3 nTPM
- thyroid gland: 5.2 nTPM
- adrenal gland: 3.9 nTPM
- lung: 3.9 nTPM
Single-cell type
- respiratory ciliated cells: 815 nCPM
- fallopian tube ciliated cells: 672 nCPM
- epididymal efferent duct ciliated cells: 570 nCPM
- ependymal cells: 428 nCPM
- endometrial ciliated cells: 333 nCPM
- choroid plexus epithelial cells: 228 nCPM
Immune cell
- eosinophil: 6.2 nTPM
- intermediate monocyte: 2.8 nTPM
- non-classical monocyte: 2.8 nTPM
- classical monocyte: 2.1 nTPM
- neutrophil: 1.8 nTPM
- myeloid DC: 1.2 nTPM
Brain region
- choroid plexus: 17 nTPM
- midbrain: 11 nTPM
- medulla oblongata: 8.3 nTPM
- spinal cord: 7.2 nTPM
- white matter: 6 nTPM
- hypothalamus: 4.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Coiled-coil domain-containing protein 170-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCDC170 as an antibody target. Whether an autoantibody or antibody against CCDC170 could matter depends on whether native CCDC170 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCDC170 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCDC170 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...